ARTICLE | Distillery Therapeutics
Transplant
May 23, 2018 6:19 PM UTC
Mouse studies suggest inhibiting DOT1L or overexpressing DUSP6 could help treat GvHD associated with T cell therapies. In a mouse model of xenogeneic T cell-associated GvHD, adoptive transfer of human...
BCIQ Company Profiles